Expression of the extracellular matrix protein tenascin in laryngeal epithelial lesions: Correlation with fibronectin, CD44, cathepsin D and proliferation indices

Virchows Archiv

Volumn 436, Issue 6, 2000, Pages 579-584

  Goussia, Ann C ^a   Ioachim, Elli E ^a   Peschos, Dimitrios ^a   Assimakopoulos, Dimitrios A ^a   Skevas, Antonios ^a   Agnantis, Niki J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Cathepsin D; CD44; Fibronectin; Laryngeal lesions; Tenascin

Indexed keywords

CATHEPSIN D; CYCLINE; FIBRONECTIN; HERMES ANTIGEN; KI 67 ANTIGEN; SCLEROPROTEIN; TENASCIN;

ARTICLE; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION FUNCTION; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KERATOSIS; LARYNX CARCINOMA; LARYNX MUCOSA; LARYNX PAPILLOMATOSIS; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD44; CATHEPSIN D; EPITHELIUM; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL DISEASES; LARYNGEAL NEOPLASMS; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; TENASCIN;

EID: 0034043069     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004289900174     Document Type: Article

References (38)

1. 1. Aufderheide E, Ekblom P (1988) Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms and dependence on epithelial-mesenchymal interactions. J Cell Biol 107:2341-2349
2. 2. Aufderheide E, Chiquet-Ehrismann R, Ekblom P (1987) Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol 105:599-608
3. 3. Bardos H, Juhasz A, Repassy G, Adany R (1998) Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx. Thromb Haemost 80:767-772
4. 4. Bronner-Fraser M (1998) Distribution and function of tenascin during cranial neural crest development in the chick. J Neurosci Res 21:135-147
5. 5. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakatura T (1986) Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131-139
6. 6. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M (1988) Tenascin interferes with fibronectin action. Cell 53: 383-390
7. 7. Ekblom P, Aufderheide E (1989) Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. Int J Dev Biol 33:71-79
8. 8. Erickson HP, Bourdon MA (1989) Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Ann Rev Cell Biol 5:71-92
9. 9. Flaumenhaft R, Rifkin DB (1991) Extracellular matrix regulation of growth factor and protease activity. Curr Opin Cell Biol 3:817-823
10. 10. Gould VE, Koukoulis GK, Virtanen I (1990) Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast. Cell Diff Dev 32:409-416
11. 11. Goussia A, Ioachim E, Peschos D, Assimakopoulos D, Vougiouklakis Th, Skevas A, Agnantis NJ (1999) Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices. Anticancer Res 19:3055-3060
12. 12. Hanamura N, Yoshida T, Matsumoto E, Kawarada Y, Sakakura T (1997) Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas. Int J Cancer 73:10-15
13. 13. Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukoulis GK, Gould VE (1990) Differential distribution of tenascin in the normal, hyperplastic and neoplastic breast. Lab Invest 63: 798-806
14. 14. Ioachim E, Assimakopoulos D, Goussia AC, Peschos D, Skevas A, Agnantis NJ (1999) Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA. Histol Histopathol 14:1113-1118
15. 15. Ishihara A, Yoshida T, Tamaki H, Sakamura T (1995) Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1:1035-1041
16. 16. Jahkola T, Toivonen T, Nordling S, von Smitten K, Virtanen I (1998) Expression of tenascin C in intraductal carcinoma of human breast: relationship to invasion. Eur J Cancer 34: 1687-1692
17. 17. Jahkola T, Toivonen T, Smitten K von, Virtanen I, Masenius V-M, Blomqvist (1999) Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors. Br J Cancer 80:167-174
18. 18. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I (1991) Tenascin in normal, reactive, hyperplastic and neoplastic tissues: biologic and pathologic implications. Hum Pathol 22:636-643
19. 19. Kratochwil K (1969) Organ specificity in mesenchymal induction demonstrated in the embryonic development of the mammary gland of the mouse. Dev Biol 20:46-71
20. 20. Lee SK, Park SC, Chi JG, Sakamato F, Shresta P, Mori M (1995) Expression of tenascin in hamster buccal pouch mucosa during experimental carcinogenesis. Oral Oncol Eur J Cancer 31:188-192
21. 21. Lightner VA, Marks JR, McCachren SS (1994) Epithelial cells are an important source of tenascin in normal and malignant human breast tissue. Exp Cell Res 210:177-184
22. 22. Ostwald J, Pracht O, Rhode E, Kramp B (1997) Are the products of CD44 exons v5 and v6 markers for metastasis of laryngeal carcinomas? Laryngorhinootologie 76:295-299
23. 23. Panizzut B, Carlevato MT, Ferro S, Cavalot AL, Gervasio CF, Ricci E, Trusolino L, Marchisio PC, Cortesina G (1997) Adhesion molecules in squamous cell carcinoma of the larynx: possible indication of prognosis. Acta Otorhinolaryngol Ital 17: 347-356
24. 24. Pilch H, Schaffer U, Schienger K, Lautz A, Tanner B, Hockel M, Knapstein PG (1999) Expression of tenascin in human cervical cancer-association of tenascin expression with clinicopathological parameters. Gynecol Oncol 73:415-421
25. 25. Riedl S, Faissner A, Schlag P, Herbay AV, Koretz K, Moller P (1992) Altered content and distribution of tenascin in colitis, colon adenoma and colorectal carcinoma. Gastroenterology 103: 400-406
26. 26. Sasano H, Nagura H, Watanabe K, Ito K, Tsuiki A, Sato S, Yajima A, Kusakabe M, Sakakura T (1993) Tenascin expression in normal and abnormal human endometrium. Mod Pathol 6:323-326
27. 27. Schwartzbauer JE (1991) Fibronectin: from gene to protein. Curr Opin Cell Biol 3:786-791
28. 28. Shanmugaratnam K, Sobin LH (ed) (1991) Histological typing of tumours of the upper respiratory tract and ear. Springer, Berlin Heidelberg New York
29. 29. Shoji T, Kamiya T, Tsubura A, Hatano T, Sakakura T, Yamamoto M, Morii S (1992) Immunohistochemical staining patterns of tenascin in invasive breast carcinomas. Virchows Arch 421:53-56
30. 30. Siri A, Carnemolla B, Saginati M, Leprini A, Casari G, Baralle F, Zardi L (1991) Human tenascin: primary structure, premRNA splicing patterns and localization of the epitopes recognized by to monoclonal antibodies. Nucleic Acids Res 19: 525-531
31. 31. Slater M (1996) Dynamic interactions of the extracellular matrix. Histol Histopathol 11:175-180
32. 32. Soini Y, Paakko P, Virtanen I, Lehto V-P (1992) Tenascin in salivary gland tumours. Virch Arch 421:217-222
33. 33. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA (1996) Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122:627-632
34. 34. Tiita O, Wahlstrom T, Virtanen I, Gould VE (1993) Tenascin in inflammatory conditions and neoplasm of the urinary bladder. Virch Arch 63:283-287
35. 35. Vollmer G (1997) Biologic and oncologic implications of tenascin-C/hexabrachion proteins. Crit Rev Oncol Hematol 25: 187-210
36. 36. Wilson KE, Langdon SP, Lessells AM, Miller WR (1996) Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br J Cancer 74:999-1004
37. 37. Yoshida T, Matsumoto E-I, Hanamura N, Kalembeyi I, Katsuta K, Ishihara A, Sakakura T (1997) Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. J Pathol 182:421-428
38. 38. Zirbes TK, Baldus SE, Moenig SP, Schmilz K, Thiele J, Holscher AH, Dienes HP (1999) Tenascin expression in gastric cancer with special emphasis on the WHO-lauren-, and goseki-classifications. Int J Mol Med 4:39-42